Table 3.

The Log Rank analysis of factors for survival benefit in the experimental group.

		OS		PFS
Variable	NO.	Median (95% CI)	P	Median (95% CI)	P
Age			0.442		0.176
＞65	12	520 (257.9–955.6)		127 (78.6–185.8)
≤ 65	13	496 (335.7–1065.7)		200 (116.2–316.4)
Gender			0.783		0.873
Male	20	410 (348.8–874.9)		144 (112.9–250.1)
Female	5	663 (57.3–1603.9)		135 (27.8–279.4)
BCLC			0.001*		0.001*
B	10	588 (300.6–1261.6)		273.5 (141.7–382.1)
C	15	442 (298.0.6–845.8)		97 (78.1–159.0)
ECOG score			0.213		0.417
0–1	13	379 (227.3–866.66)		126 (87.9–198.7)
≥ 2	12	621 (386.8–1159.7)		181 (102.3–320.0)
Hypertension			0.121		0.869
Yes	17	579 (382.7–1070.4)		135 (98.9–260.4)
No	8	393 (324.9–684.6)		144 (92.4–243.3)
Hand-foot syndrome			0.056		0.838
Yes	15	343 (248.2–517.1)		111 (94.4–215.1)
No	10	737.5 (580.5–1549.5)		154 (83.8–331.4)

NO. = the number of the patients